FierceBiotech 23. Feb. 2026 UPDATED: FDA illuminates new approval pathway for bespoke gene editing therapies
FierceBiotech 14. Jan. 2026 JPM26: Illumina working with China on 'a path through' its export troubles, sees academic research environment 'muted' for '26
FierceBiotech 9. Jan. 2026 Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
FierceBiotech 9. Jan. 2026 Illumina hires former NHGRI Director Eric Green as new chief medical officer